UCSF Helen Diller Family Comprehensive Cancer Center
@ucsfcancer.bsky.social
1.2K followers 400 following 120 posts
Championing basic science, clinical research, epidemiology/cancer control, and patient care. cancer.ucsf.edu
Posts Media Videos Starter Packs
ucsfcancer.bsky.social
ʻButte, his friends say, will be remembered not just as a star physician-scientist but as one who shined his bright light on others to help them dream as big as he did.ʻ

A fitting tribute to the legacy of @atulbutte.bsky.social @ucsanfrancisco.bsky.social via @jama.com
jama.com
JAMA @jama.com · 5d
Atul Butte, MD, PhD, helped define the field of translational bioinformatics and inspired countless colleagues and trainees.

He will be remembered for his brilliant mind, infectious optimism, generous mentorship.
Remembering Atul Butte
This Medical News article is in remembrance of Atul Butte, MD, PhD, a pioneer in using data science to improve health.
jamanetwork.com
ucsfcancer.bsky.social
Friday, October 10th at 4pm | UCSF Cancer Center Seminar Series in Basic and Translational Research. Dolores Hambardzumyan, PhD, MBA from Perelman School of Medicine, UPenn presents "Myeloid heterogeneity and their role in high-grade gliomas"
See full schedule: cancer.ucsf.edu/seminars
Dolores Hambardzumyan, PhD, MBA
Reposted by UCSF Helen Diller Family Comprehensive Cancer Center
neurosurgucsf.bsky.social
UCSF neurosurgeon @herveyjumper.bsky.social & his @umich.edu colleagues have developed an intraoperative tool called FastGlioma that uses AI to help neurosurgeons see in real-time where tumor cells have infiltrated brain tissue. 🧪 braintumorcenter.ucsf.edu/news/how-ai-...
@ucsfcancer.bsky.social
 Graphic showing an MRI scan of a low grade glioma below a headline that says, How AI is Changing Brain Tumor Surgery. Subheading says: High-tech imaging approaches allow neurosurgeons to interpret tissue samples during surgery to remove previously invisible malignant cells. Quote card showing Shawn Hervey-Jumper, MD, a UCSF neurosurgeon and the Mitchel S. Berger, MD Endowed Professor of Neurosurgery, during an awake brain surgery. He is quoted saying: With this new technology, we can deliver safer, more complete tumor resections.
ucsfcancer.bsky.social
At #ASTRO25 and looking for a new landing spot in #RadOnc? Connect with us via @ucsfradonc.bsky.social or find our experts at the conference: cancer.ucsf.edu/news/2025/09...
ucsfcancer.bsky.social
There are usually no signs or symptoms of prostate cancer, but it can be found early enough to be treated and cured with just a simple blood test – the PSA test. Learn more from the San Francisco Cancer Initiative:
Prostate Cancer | SFCancer.org
Home
ow.ly
Reposted by UCSF Helen Diller Family Comprehensive Cancer Center
ucsanfrancisco.bsky.social
Why does #NIHfunding matter? Because it drives discoveries like engineered fat cells that can starve breast, colon, pancreatic, and prostate cancers. tiny.ucsf.edu/SavingLivesW...
ucsfcancer.bsky.social
On #WorldCancerResearchDay, we affirm that cancer research needs us all. Announcing our 2025-2026 @ucsanfrancisco.bsky.social Global Cancer Program Fellows, joining us from Tanzania, Rwanda, and Vietnam #WCRD2025 #CancerResearchNeedsUsAll #UCSFGlobalCancerProgram
Fellows
Mwajuma Jumbe, MD, MMED, is a Women's Imaging Super-specialist at Muhimbili National Hospital and serves as an honorary lecturer at Muhimbili University of Health and Allied Sciences (MUHAS). She…
globalcancer.ucsf.edu
Reposted by UCSF Helen Diller Family Comprehensive Cancer Center
ucsfradonc.bsky.social
Congratulations to David Raleight Lab - to investigate the genomic and biochemical mechanisms underlying differences in meningioma outcomes! @ucsfcancer.bsky.social Awarded $12M Research Grant to Improve Cancer Outcomes @neurosurgucsf.bsky.social www.newswise.com/articles/ucs...
ucsfcancer.bsky.social
Excited to have been awarded a Specialized Programs of Research Excellence (SPORE) grant by the NCI to provide resources for translational research into genomic, biochemical, and environmental drivers of cancers outcomes @ucsanfrancisco.bsky.social
cancer.ucsf.edu/news/2025/09...
#CancerResearch
ucsfcancer.bsky.social
BRCA and Hereditary Cancer Workshop - I Tested Positive For Cancer Risk: What Does This Mean and What Can I Do?
Tuesday, September 23, 2025 5:30pm to 7pm @ucsanfrancisco.bsky.social @ucsfhealth.bsky.social
calendar.ucsf.edu/event/brca-a...
BRCA and Hereditary Cancer Workshop at UCSF
ucsfcancer.bsky.social
Friday, September 19th at 4pm | UCSF Cancer Center Seminar Series in Basic and Translational Research continues with presentation from Francisco Sánchez-Rivera, PhD @fsrmit.bsky.social from MIT.
See full schedule: lnkd.in/gbcwrrSt
Francisco Sánchez-Rivera, PhD
ucsfcancer.bsky.social
Bridging the Gap: Molecular Profiling to Guide Treatment Selection in Metastatic Pancreatic Cancer | Journal of Clinical Oncology ascopubs.org/doi/10.1200/...
Drs. Andrew Ko @ucsanfrancisco.bsky.social and Mandana Kamgar, Medical College of Wisconsin
Bridging the Gap: Molecular Profiling to Guide Treatment Selection in Metastatic Pancreatic Cancer
ascopubs.org
ucsfcancer.bsky.social
Reminder - tomorrow Sept 12th at 4pm | UCSF Cancer Center Seminar Series in Basic and Translational Research 2025 series kicks off with Paul Northcott, PhD @doctorpauln77.bsky.social @sjcenos.bsky.social See full schedule: cancer.ucsf.edu/seminars
LinkedIn
This link will take you to a page that’s not on LinkedIn
lnkd.in
ucsfcancer.bsky.social
Kudos to all the runners and their supporters this past weekend for the Run Tiburon @ucsanfrancisco.bsky.social Courage Over Cancer fundraiser benefitting our Cancer Survivorship and Wellness Institute. #UCSFProud
alaffan.bsky.social
Today 800+ runners greeted the sunrise to run in support of #ucsfcancersurvivorship. Patients clinicians and San Francisco Bay Area locals joining together in health and solidarity. What an amazing day #ucsfhdfccc #ucsf #runtiburon
ucsfcancer.bsky.social
"I plan to share this prize with my lab, where we’re exploring new ways to target KRAS mutations and bring forward therapies that could make a real difference for patients.” Dr. Frank McCormick @ucsanfrancisco.bsky.social | www.businesswire.com/news/home/20...
ucsfcancer.bsky.social
DYK? Screening options for prostate cancer, which include an exam and a blood test for prostate-specific antigen (PSA), often catch the disease before it spreads. As a result, the five-year survival rate is 97.5%. Info on #ProstateCancerAwareness @theaacr.bsky.social
September is Prostate Cancer Awareness Month
September is Prostate Cancer Awareness Month. It's the most common non-skin cancer in men, and the second deadliest (after lung cancer).
www.aacr.org